Table 2 Qualitative data representing the pharmacokinetic profile of NCF

From: Nanocurcumin–pyrroloquinoline formulation prevents hypertrophy–induced pathological damage by relieving mitochondrial stress in cardiomyocytes under hypoxic conditions

Parameters

Results

k el

0.017±0.007

AUC0–t (mg ml−1 min−1)

1.19±0.44

AUC0–∞ (mg ml−1 min−1)

2.55±0.63

t1/2 (min)

28.55±18.11

Vd (l kg−1)

40.11±13.29

Cl (l kg−1 min−1)

84±27.27

MRT (min)

58.22±29.56

kα (l min−1)

0.22±0.10

Cmax (mg ml−1)

0.03±0.002

tmax (min)

13.09±4.1

  1. Abbreviations: AUC, area under curve; MRT, mean residence time; NC, nanocurcumin; NCF, nanocurcumin formulation.
  2. Data are represented as the means±s.d. from three independent experiments.
Back to article page